Treatment of Iron-Deficiency Anemia in Inflammatory Bowel Disease
Iron-deficiency anemia is a recognised complication of inflammatory bowel disease. Managing it effectively requires understanding why the anemia developed in this specific context — and tailoring the approach to the patient's current disease state.
Clinical Scenario
This protocol applies to patients with inflammatory bowel disease who have iron-deficiency anemia. The first clinical step is establishing whether the anemia reflects inadequate iron intake or absorption, or ongoing iron loss — most commonly from gastrointestinal bleeding related to active disease.
Treatment Approach
The approach combines management of the underlying inflammatory activity with iron supplementation, which is indicated for all patients in this setting. The appropriate form and route of iron delivery are determined by the degree of disease activity and individual patient factors — more than one option exists, and the full decision framework is detailed in the protocol.
The complete treatment algorithm — including the choice between different iron delivery strategies based on disease status — is available via the structured protocol below.
References
In individuals with inflammatory bowel disease and iron-deficiency anemia, clinicians first should determine whether iron-deficiency anemia is owing to inadequate intake or absorption, or loss of iron, typically from gastrointestinal bleeding.
Active inflammation should be treated effectively to enhance iron absorption or reduce iron depletion.
Treatment should include optimizing medical management of the underlying inflammation, as well as dietary intervention.
Iron supplementation should be given to all patients with IBD and IDA.
Intravenous iron therapy should be given in individuals with inflammatory bowel disease, iron-deficiency anemia, and active inflammation with compromised absorption.
Oral iron may be appropriate in carefully selected patients with IBD who have mild anemia, whose disease is clinically inactive, and who are able to tolerate oral iron.
DOI: 10.1016/j.cgh.2024.03.046
View source ↗